We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$5.76B
AUM Growth
+$32.7M
Cap. Flow
+$188M
Cap. Flow %
3.27%
Top 10 Hldgs %
50.49%
Holding
248
New
70
Increased
46
Reduced
39
Closed
50

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$136M
2
FRPT icon
Freshpet
FRPT
+$91.3M
3
ROST icon
Ross Stores
ROST
+$81.3M
4
FIVE icon
Five Below
FIVE
+$72.6M
5
EXAS
Exact Sciences
EXAS
+$64.3M

Top Sells

Rank Stock Value
1
DG icon
Dollar General
DG
+$75.6M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$71.5M
3
ILMN icon
Illumina
ILMN
+$62.5M
4
AZN icon
AstraZeneca
AZN
+$55.2M
5
TSCO icon
Tractor Supply
TSCO
+$51.8M

Sector Composition

Rank Sector Weight
1 Healthcare 43.48%
2 Miscellaneous 31.17%
3 Consumer Discretionary 9.47%
4 Consumer Staples 8.21%
5 Technology 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNCWW
176
CEA Industries Inc Warrant
BNCWW
$23.7K
$105K ﹤0.01%
700,000
– –
MOBBW
177
Mobilicom Ltd Warrants
MOBBW
$92K ﹤0.01%
+242,100
New +$93.2K
CINGW icon
178
Cingulate Inc Warrants
CINGW
$26.1K
$90K ﹤0.01%
410,000
– –
RVSNW icon
179
Rail Vision Ltd Warrant
RVSNW
$926K
$90K ﹤0.01%
1,089,500
– –
APCXW
180
DELISTED
AppTech Payments Corp Warrant
APCXW
$89K ﹤0.01%
715,000
– –
PETVW
181
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$87K ﹤0.01%
200,000
– –
LUCYW icon
182
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$73K
$84K ﹤0.01%
+210,000
New +$139K
EDBLW
183
Edible Garden AG Warrant
EDBLW
$124K
$81K ﹤0.01%
800,000
– –
NEXRW
184
Nexera Technologies Ltd Warrant
NEXRW
$80K ﹤0.01%
+480,769
New +$132K
ONFOW icon
185
Onfolio Holdings Warrant
ONFOW
$87.6K
$74K ﹤0.01%
+400,000
New +$70.9K
SVREW
186
SaverOne 2014 Ltd Warrant
SVREW
$44.7K
$73K ﹤0.01%
242,100
– –
BIAFW icon
187
bioAffinity Technologies
BIAFW
$956K
$72K ﹤0.01%
+204,082
New +$212K
GROMW
188
DELISTED
Grom Social Enterprises Inc. Warrants
GROMW
$65K ﹤0.01%
24,100
– –
NXLIW
189
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$58K ﹤0.01%
+325,000
New +$65K
DBGIW
190
DELISTED
Digital Brands Group, Inc. Warrant
DBGIW
$43K ﹤0.01%
7,229
– –
LCFYW icon
191
Locafy Ltd Warrant
LCFYW
$450K
$40K ﹤0.01%
12,121
– –
DRMAW
192
DELISTED
Dermata Therapeutics Warrant
DRMAW
$31K ﹤0.01%
325,000
– –
AREBW
193
DELISTED
American Rebel Holdings Warrants
AREBW
$29K ﹤0.01%
4,819
– –
IVDAW icon
194
Iveda Solutions Warrant
IVDAW
$23K ﹤0.01%
145,000
– –
AIMDW icon
195
Ainos Warrants
AIMDW
$62.5K
$19K ﹤0.01%
+25,000
New +$16.1K
SQLLW
196
DELISTED
SeqLL Inc. Warrant
SQLLW
$4K ﹤0.01%
50,000
– –
UPH.WS
197
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
$1K ﹤0.01%
10,000
– –
ABVC icon
198
ABVC BioPharma
ABVC
$28.5M
– –
-109,275
Closed -$1.16M
BNBX
199
DELISTED
BNB PLUS CORP
BNBX
– –
-27
Closed -$295K
AVTR icon
200
Avantor
AVTR
$10.4B
– –
-1,000,000
Closed -$31.1M
6 7
8
9 10

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Armistice Capital held 248 positions worth $5.76B, up 0.57% from $5.73B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital deployed $188M of net new capital in Q3 2022, opening 70 new positions and adding to 46 existing holdings. Its largest new stake was GSK: 3,600,000 shares worth $106M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $46.6M trimmed.

  • Armistice Capital's largest Q3 2022 buy was GSK: 3,600,000 shares worth $106M.
  • Armistice Capital added most to Freshpet in Q3 2022, an estimated $91.3M increase.
  • Armistice Capital's biggest Q3 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $46.6M.
  • Armistice Capital fully exited Dollar General in Q3 2022, selling an estimated $75.6M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.76B portfolio in Q3 2022.
  • Armistice Capital opened 70 new positions and closed 50 in Q3 2022.
  • Armistice Capital's portfolio value rose 0.57% quarter-over-quarter to $5.76B.

Based on Armistice Capital's 13F filing for Q3 2022, filed 14 Nov 2022.